Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioChemics Awarded Patent for Development of Bifunctional Synthetic Molecules

Published: Thursday, January 31, 2013
Last Updated: Thursday, January 31, 2013
Bookmark and Share
A novel drug delivery and efficacy enhancement technology.

BioChemics announced today that it has received a patent for a new breakthrough drug delivery technology. This technology called Bifunctional Synthetic Molecule, or BSM, involves covalently bonding two existing different molecules together to create a unique, new and chemically-stable molecule which contains desired physicochemical properties for the purpose of enhanced dermal, or other tissue, penetration. BSM also provides co-localization of the different components of the new molecule in the target tissue at the same time, further enhancing efficacy of the drug.

These new molecules allow BioChemics to create new chemical entities (NCE’s) with bifunctional characteristics that are, in some examples, designed to have superior tissue penetration properties and tissue targeting properties. In other examples, the BSM is designed to have a covalent bond that is both tissue-specific and enzyme-labile that releases the different functionalities of the BSM once it is deposited at the target tissue. The multiple functionalities, impacting the target tissue simultaneously, boosts efficacy and enhances disease therapy. We believe that this technology gives BioChemics the potential to re-engineer many existing drugs creating new classes of pharmaceutical agents that have an enhanced efficacy, enhanced pharmacology, and improved safety profiles. The BSM technology is designed to enhance the delivery of drugs and to improve the therapeutic index of the drug by promoting the optimal tissue distribution for maximum therapeutic impact.

“I am excited that we have been awarded this new technology,” said John Masiz, President of BioChemics Inc. “This technology may allow us to create ‘smart drugs’ that have the ability to find the specific diseased tissue target in the body and then concentrate the active drug into that specific tissue for a better therapeutic event. Further, this technology may minimize side effects since non-targeted tissue will not be impacted. This new system continues to build on BioChemics’ predecessor VALE technology and further confirms that advances in drug delivery will be the major source of pharmaceutical advancement over the next decade.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!